These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4646494)

  • 1. [Immuno-epidemiological effectiveness of Beckenham's measles vaccine].
    Topciu V; Arion R; Moldovan E; Olaru G; Csaky N; Băcilă E; Halasz C; Weitzen O; Dan G; Mîrza I; Magyorosi E; Jeremias N; Nicolau D; Yampan R
    Stud Cercet Virusol; 1972; 23(2):145-50. PubMed ID: 4646494
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Single or double dose of vaccine needed for the eradication of measles in Spain?].
    Vitoria Miñana I; Morales Suárez-Varela M; Cotanda Gutiérrez P; Asensi Botet F
    An Esp Pediatr; 1993 Feb; 38(2):130-4. PubMed ID: 8439098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative value of 3 anti-measles vaccines with attenuated live virus. Immuno-epidemiological study].
    Topciu V; Arion R; Moldovan E; Csaky N; Olaru G
    Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):119-27. PubMed ID: 5096857
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of the first trials of measles vaccination in France, with the hyperattenuated live cirus vaccine (Schwartz strain)].
    Mande R; Jammet ML; Celers J; Boué A
    Arch Fr Pediatr; 1967 Jan; 24(1):105-6. PubMed ID: 6031447
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Measles today].
    Feo F; Angela GC
    Minerva Med; 1966 Mar; 57(22):954-73. PubMed ID: 5948625
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of measles and measles vaccines on diphtherial immunity].
    Dumkina NV
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():257-60. PubMed ID: 5860946
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vaccination against measles].
    Cathala F
    Presse Med (1893); 1967 Sep; 75(38):1869-70. PubMed ID: 6066139
    [No Abstract]   [Full Text] [Related]  

  • 14. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of the live AMN USSR measles vaccine from the ESC strain and its use and problems of mass vaccinations against measles].
    Czumakow MP; Woroszylowa MK; Graczew WP; Sinjak KM; Bojko WM; Sejbil WB; Rodin WI; Piwień GG
    Przegl Epidemiol; 1970; 24(2):205-11. PubMed ID: 5431794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
    Topciu V; Moldovan E; Csaky N; Băcilă E
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-immunological characteristics of measles in children vaccinated with a live measles vaccine].
    Smorodinova IP; Shikina ES
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():102-8. PubMed ID: 4808371
    [No Abstract]   [Full Text] [Related]  

  • 19. Says many children still unnecessarily have measles.
    Agate GH
    Mich Med; 1967 Feb; 66(3):208. PubMed ID: 6037141
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.